Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Appropriate Opioid Prescription Quantities for Acute Pain Treatment
NCT04484610Phase 4Completed
- Sponsor
- Center for Addiction and Mental Health
- Start
- Sep 2020
- Primary completion
- Feb 2022
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in acute pain and opioid use disorder (OUD) (2 arms), sponsored by Center for Addiction and Mental Health. Primary endpoint: Opioid Quantities Dispensed at 6 months. Started Sep 2020; status: completed.
02
Conditions
acute painopioid use disorder (OUD)
Beyond the preview
Go deeper on NCT04484610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04484610.